Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The ...

Institutional support and a healthy fundamental backdrop make this company worth investigating. As you can see, VEEV has had strong sales and earnings growth: Also, EPS is estimated to ramp higher ...

Veeva Systems exceeded earnings expectations for Q4 2025, while demonstrating solid revenue growth and guided an optimistic ...

Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...

Shares of Veeva Systems (NYSE: VEEV) are posting big gains in Thursday's trading despite broader sell-offs for the tech ...

Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They ...

Veeva Systems (VEEV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates ...

Here are the key highlights. What Happened: Veeva reported fourth-quarter revenue of $720.9 million, up 14% year-over-year.

Veeva released Q4 result on March 5 th, reporting 14.3% revenue growth and 28.7% adj. operating profit growth, as detailed in ...

Subscription services revenue rose to $608.6 million, marking a 16.7% year-over-year growth. Veeva Systems exceeded earnings expectations for Q4 2025, while demonstrating solid revenue growth and ...